Tabituximab
Based on 1 Customer Validation
Tabituximab (OTSA101) is a humanized monoclonal antibody against frizzled class receptor 10 (FZD10).
For research use only. We do not sell to patients.
- Purity : ≥99.0%
- CAS No.: 1644134-10-0
- Molecular Weight:144.64 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
FZD10
In Vitro
Non-radiolabeled Tabituximab (OTSA101) antibody has only weak antagonistic activity on synovial sarcoma cell growth[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Frizzled-10/CD350 Protein, Human (HEK293, His, HY-P74146) can bind Tabituximab. The EC50 for this effect is 2.961 ng/mL.
Chemical Information
-
CAS No. 1644134-10-0
-
Appearance Liquid
-
Molecular Weight 144.64 kDa
-
Color Colorless to light yellow
-
SMILES
[Tabituximab]
-
Synonyms
ONC-005, OTSA101
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)